proxyvotesnow.com

Home › Companies › SPRINGWORKS THERAPEUTICS INC. › 2024-2025

SPRINGWORKS THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and SPRINGWORKS THERAPEUTICS INC.’s Form 8-K, filed 2025-05-14 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 9Reported items
  • 327Asset managers
  • 2,475Fund votes
  • 2025-05-14Main meeting date

Proxy season: 2023-2024 2024-2025

Explore SPRINGWORKS THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by SPRINGWORKS THERAPEUTICS INC.

These tallies are SPRINGWORKS THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-14 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

SPRINGWORKS THERAPEUTICS INC. — official shareholder meeting results, meeting held 2025-05-14
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Alan Fuhrman 43,174,031--5,849,167 18,299,1645,849,167 Majority: yes
Elect Director: Julie Hambleton, M.D. 58,259,812--5,849,167 3,213,3835,849,167 Majority: yes
Elect Director: Daniel S. Lynch, M.B.A. 57,963,373--5,849,167 3,509,8225,849,167 Majority: yes
Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year endi 66,999,344306,31216,706 ---- Majority: yes
Proposal 3 - Non-Binding Advisory Vote on Executive Compensation The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the a 57,606,7023,851,0465,864,614 --5,864,614 Majority: yes

Source: SPRINGWORKS THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-05-14 — read the filing on EDGAR.

How asset managers voted at the SPRINGWORKS THERAPEUTICS INC. 2024-2025 meetings

Each item below shows how the 327 asset managers that disclosed a SPRINGWORKS THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of SPRINGWORKS THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Non-binding advisory vote on executive compensation

COMPENSATIONMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 9 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 57,606,702AGAINST: 3,851,046

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Proposal 3 - Non-Binding Advisory Vote on Executive Compensation The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy”): 57,606,702 for, 3,851,046 against, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 282 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 95%
FOR: 95.0%AGAINST: 4.2%ABSTAIN: 0.0%SPLIT: 0.7%DID NOT VOTE: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “Non-binding advisory vote on executive compensation” at SPRINGWORKS THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity18,936,4800 00For
Vanguard7,814,9582 00For
BlackRock4,770,3320 00For
T. Rowe Price4,539,6750 00For
State Street4,173,8832,675 00For
Woodline Partners LP2,069,4910 00For
GEODE CAPITAL MANAGEMENT, LLC1,704,8190 00For
Voya1,703,1070 00For
ArrowMark Colorado Holdings LLC1,443,3710 00For
BNP Paribas Asset Management Holding S.A.01,257,395 00Against
PICTET ASSET MANAGEMENT SA1,231,6570 00For
Charles Schwab1,222,5860 00For
DE Shaw1,174,8430 00For
Fiera Capital Corp1,154,2160 00For
ALPINE ASSOCIATES MANAGEMENT INC.1,002,6880 00For
Invesco955,3450 00For
ORBIMED ADVISORS LLC950,2000 00For
GW&K Investment Management, LLC180,0160 00Split
Victory Capital702,5610 00For
PRINCIPAL GLOBAL INVESTORS692,5300 00For
Catalio Capital Management, LP678,6770 00For
Northern Trust604,7280 00For
Columbia Threadneedle561,0290 00For
Dimensional519,4540 00For
Principal485,4360 00For

Showing the 25 largest of 282 asset managers. See all 282 in the interactive database.

2. A proposal to approve, on a non- binding, advisory basis, certain compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-26; no official results are on file for this meeting.

Combines 5 wordings of this item as funds reported it.

90% fund support · no official result

FOR 90%10%

The 236 asset managers below cast 90% of the shares they voted on this item FOR (50,524,028 for, 5,381,018 against).

FOR: 50,524,028 (90.0%)AGAINST: 5,381,018 (9.6%)ABSTAIN: 153,696 (0.3%)DID NOT VOTE: 77,283 (0.1%)
Largest asset managers voting on “A proposal to approve, on a non- binding, advisory basis, certain compensation that may be paid or become paya” at SPRINGWORKS THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard7,327,2010 00For
BlackRock6,546,5420 00For
Pentwater Capital Management LP4,885,7770 00For
Fidelity3,271,0741,531,580 00For
State Street3,959,4052,587 00For
Investment Managers Series Trust II1,909,8500 00For
GEODE CAPITAL MANAGEMENT, LLC01,733,020 00Against
Charles Schwab1,205,1780 00For
Beryl Capital Management LLC1,161,0560 00For
TIG Advisors, LLC988,3470 00For
GLAZER CAPITAL, LLC961,9430 00For
UBS887,66566,723 00For
Invesco922,1590 00For
AllianceBernstein0827,553 00Against
Magnetar Financial LLC822,2420 00For
PRINCIPAL GLOBAL INVESTORS751,0470 00For
GW&K Investment Management, LLC749,3080 00For
Voya60,133687,506 00Against
WATER ISLAND CAPITAL LLC661,1550 00For
Woodline Partners LP623,1770 00For
NEXPOINT ASSET MANAGEMENT, L.P.620,4300 00For
NEXPOINT FUNDS I620,4300 00For
Northern Trust612,1420 00For
ArrowMark Colorado Holdings LLC573,7350 00For
Principal526,1220 00For

Showing the 25 largest of 236 asset managers. See all 236 in the interactive database.

3. Ratification of the appointment of Ernst & Young LLP as SpringWorks Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2025

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 4 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 66,999,344AGAINST: 306,312

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for ”): 66,999,344 for, 306,312 against, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 73 asset managers below cast 99.9% of the shares they voted on this item FOR (28,238,351 for, 751 against).

FOR 99.9%
FOR: 28,238,351 (100.0%)AGAINST: 751 (0.0%)ABSTAIN: 5,790 (0.0%)
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as SpringWorks Therapeutics' independent registered publi” at SPRINGWORKS THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity7,789,3270 00For
Vanguard7,559,7240 00For
BlackRock2,242,4470 00For
T. Rowe Price1,947,1900 00For
State Street1,423,1260 00For
Voya757,9070 00For
Charles Schwab611,2290 00For
Columbia Threadneedle561,0290 00For
Principal485,4360 00For
Dimensional429,5880 00For
Invesco426,0700 00For
MERIDIAN FUND INC388,4100 00For
MFS309,4880 00For
TIAA298,6330 00For
Lord Abbett287,3020 00For
Victory Capital232,8140 00For
New York Life224,7710 00For
Equitable189,5190 00For
Jackson National148,2260 00For
Putnam147,5550 00For
MoA Funds Corp140,6980 00For
Bridge Builder Trust136,0420 00For
AMG FUNDS128,1250 00For
John Hancock123,0780 00For
QUANTITATIVE MASTER SERIES LLC117,1560 00For

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

4. Election of Class III Directors: Alan Fuhrman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 3 wordings of this item as funds reported it.

70% Majority: yes · of votes cast

FOR 70%WITHHELD 30%
FOR: 43,174,031WITHHELD: 18,299,164

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Alan Fuhrman”): 43,174,031 for, 18,299,164 withheld, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 72 asset managers below cast 100% of the shares they voted on this item FOR (22,497,524 for, 0 against).

FOR 80%ABSTAIN 20%
FOR: 22,497,524 (79.8%)ABSTAIN: 5,679,222 (20.2%)
Largest asset managers voting on “Election of Class III Directors: Alan Fuhrman” at SPRINGWORKS THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity7,789,2270 1000For
Vanguard7,559,7240 00For
BlackRock2,179,3270 63,1200For
T. Rowe Price1,947,1900 00For
State Street2,8020 1,420,3240Abstain
Voya00 757,9070Abstain
Charles Schwab611,2290 00For
Columbia Threadneedle561,0290 00For
Principal1360 485,3000Abstain
Dimensional00 429,5880Abstain
Invesco00 426,0700Abstain
MERIDIAN FUND INC388,4100 00For
MFS00 309,4880Abstain
TIAA298,6330 00For
Lord Abbett00 287,3020Abstain
Victory Capital00 232,8140Abstain
New York Life147,6900 77,0810For
Equitable120,3890 69,1300For
Jackson National00 148,2260Abstain
Putnam147,5550 00For
MoA Funds Corp00 140,6980Abstain
Bridge Builder Trust13,3190 122,7230Abstain
AMG FUNDS128,1250 00For
John Hancock98,5960 24,4820For
QUANTITATIVE MASTER SERIES LLC117,1560 00For

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

5. Election of Class III Directors: Daniel S. Lynch, M.B.A.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 57,963,373WITHHELD: 3,509,822

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel S. Lynch, M.B.A.”): 57,963,373 for, 3,509,822 withheld, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 72 asset managers below cast 100% of the shares they voted on this item FOR (27,301,611 for, 0 against).

FOR 97%
FOR: 27,301,611 (96.9%)ABSTAIN: 875,135 (3.1%)
Largest asset managers voting on “Election of Class III Directors: Daniel S. Lynch, M.B.A.” at SPRINGWORKS THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity7,789,3270 00For
Vanguard7,559,7240 00For
BlackRock2,242,4470 00For
T. Rowe Price1,947,1900 00For
State Street1,423,1260 00For
Voya757,9070 00For
Charles Schwab611,2290 00For
Columbia Threadneedle561,0290 00For
Principal485,4360 00For
Dimensional00 429,5880Abstain
Invesco426,0700 00For
MERIDIAN FUND INC388,4100 00For
MFS00 309,4880Abstain
TIAA298,6330 00For
Lord Abbett287,3020 00For
Victory Capital232,8140 00For
New York Life224,7710 00For
Equitable120,3890 69,1300For
Jackson National140,4440 7,7820For
Putnam147,5550 00For
MoA Funds Corp140,6980 00For
Bridge Builder Trust136,0420 00For
AMG FUNDS128,1250 00For
John Hancock123,0780 00For
QUANTITATIVE MASTER SERIES LLC117,1560 00For

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

6. Election of Class III Directors: Julie Hambleton, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 58,259,812WITHHELD: 3,213,383

SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Julie Hambleton, M.D.”): 58,259,812 for, 3,213,383 withheld, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 72 asset managers below cast 100% of the shares they voted on this item FOR (27,378,439 for, 0 against).

FOR 97%
FOR: 27,378,439 (97.2%)ABSTAIN: 798,307 (2.8%)
Largest asset managers voting on “Election of Class III Directors: Julie Hambleton, M.D.” at SPRINGWORKS THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity7,789,3270 00For
Vanguard7,559,7240 00For
BlackRock2,242,4470 00For
T. Rowe Price1,947,1900 00For
State Street1,423,1260 00For
Voya757,9070 00For
Charles Schwab611,2290 00For
Columbia Threadneedle561,0290 00For
Principal485,4360 00For
Dimensional00 429,5880Abstain
Invesco426,0700 00For
MERIDIAN FUND INC388,4100 00For
MFS00 309,4880Abstain
TIAA298,6330 00For
Lord Abbett287,3020 00For
Victory Capital232,8140 00For
New York Life224,7710 00For
Equitable189,5190 00For
Jackson National140,4440 7,7820For
Putnam147,5550 00For
MoA Funds Corp140,6980 00For
Bridge Builder Trust136,0420 00For
AMG FUNDS128,1250 00For
John Hancock123,0780 00For
QUANTITATIVE MASTER SERIES LLC117,1560 00For

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

7. A PROPOSAL TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR DATES, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES IN PERSON OR BY PROXY TO APPROVE THE PROPOSAL TO ADOPT THE MERGER AGREEMENT AT THE TIME OF THE SPECIAL MEETING.

CORPORATE GOVERNANCE

Meeting held 2025-06-26; no official results are on file for this meeting.

93% fund support · no official result

FOR 93%

The 69 asset managers below cast 93% of the shares they voted on this item FOR (19,178,543 for, 1,388,002 against).

FOR: 19,178,543 (93.2%)AGAINST: 1,388,002 (6.7%)ABSTAIN: 5,796 (0.0%)
Largest asset managers voting on “A PROPOSAL TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR DATES, IF NECESSARY OR APPROPR” at SPRINGWORKS THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard7,109,4614 00For
BlackRock3,166,1160 00For
Investment Managers Series Trust II1,909,8500 00For
Fidelity1,765,3430 00For
State Street3,9221,286,111 00Against
NEXPOINT FUNDS I620,4300 00For
Charles Schwab602,5790 00For
Principal526,1220 00For
ARBITRAGE FUNDS503,3910 00For
TIAA410,4220 00For
Invesco398,8960 00For
Voya343,7530 00For
Equitable188,9490 00For
First Trust173,2180 00For
New York Life162,2080 00For
AMG FUNDS123,5250 00For
QUANTITATIVE MASTER SERIES LLC117,8620 00For
John Hancock102,9620 00For
ALTSHARES TRUST95,8620 00For
MERIDIAN FUND INC79,1010 00For
MoA Funds Corp75,7780 00For
Lincoln Financial9,06152,000 00Against
GDL FUND57,0000 00For
Morningstar Funds Trust51,0950 00For
Capital Group45,1430 00For

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.

8. A proposal to adopt the Agreement and Plan of Merger, dated as of April 27, 2025 (the "Merger Agreement"), by and among Merck KGaA, Darmstadt, Germany, a German corporation with general partners ("Parent"), EMD Holdings Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), and SpringWorks Therapeutics, Inc. (the "Company"), pursuant to which Merger Sub will

EXTRAORDINARY TRANSACTIONS

Meeting held 2025-06-26; no official results are on file for this meeting.

99.9% fund support · no official result

FOR 99.9%

The 69 asset managers below cast 99.9% of the shares they voted on this item FOR (20,572,184 for, 0 against).

FOR: 20,572,184 (100.0%)AGAINST: 0 (0.0%)ABSTAIN: 0 (0.0%)
Largest asset managers voting on “A proposal to adopt the Agreement and Plan of Merger, dated as of April 27, 2025 (the "Merger Agreement"), by ” at SPRINGWORKS THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard7,109,4650 00For
BlackRock3,166,1160 00For
Investment Managers Series Trust II1,909,8500 00For
Fidelity1,765,3430 00For
State Street1,290,0330 00For
NEXPOINT FUNDS I620,4300 00For
Charles Schwab602,5790 00For
Principal526,1220 00For
ARBITRAGE FUNDS503,3910 00For
TIAA410,4220 00For
Invesco398,8960 00For
Voya343,7530 00For
Equitable188,9490 00For
First Trust173,2180 00For
New York Life162,2080 00For
AMG FUNDS123,5250 00For
QUANTITATIVE MASTER SERIES LLC117,8620 00For
John Hancock102,9620 00For
ALTSHARES TRUST95,8620 00For
MERIDIAN FUND INC79,1010 00For
MoA Funds Corp75,7780 00For
Lincoln Financial61,0610 00For
GDL FUND57,0000 00For
Morningstar Funds Trust51,0950 00For
Capital Group45,1430 00For

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.

9. Advisory Vote on Golden Parachutes

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-26; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 5 asset managers below cast 100% of the shares they voted on this item FOR (1,888 for, 0 against).

FOR: 1,888 (100.0%)
Largest asset managers voting on “Advisory Vote on Golden Parachutes” at SPRINGWORKS THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
HC CAPITAL TRUST1,3720 00For
ALGERT GLOBAL LLC4900 00For
Coyle Financial Counsel LLC130 00For
SIERRA SUMMIT ADVISORS LLC130 00For
Taconic Capital Advisors LP00 00--

Largest SPRINGWORKS THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked by the number of SPRINGWORKS THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting.

Top SPRINGWORKS THERAPEUTICS INC. shareholders by shares voted, 2024-2025
#Asset manager Shares voted
1Fidelity 18,936,480
2Vanguard 7,814,960
3BlackRock 4,770,332
4T. Rowe Price 4,539,675
5State Street 4,176,558
6Woodline Partners LP 2,069,491
7GEODE CAPITAL MANAGEMENT, LLC 1,704,819
8Voya 1,703,107
9ArrowMark Colorado Holdings LLC 1,443,371
10BNP Paribas Asset Management Holding S.A. 1,257,395

Shown as share counts, not percentages: no shares-outstanding figure has been matched to SPRINGWORKS THERAPEUTICS INC. for the 2024-2025 season, so there is no denominator to divide by.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At SPRINGWORKS THERAPEUTICS INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held 2025-05-14 and 2025-06-26), 327 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,475 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held 2025-05-14 — Non-binding advisory vote on executive compensation — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: SPRINGWORKS THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-14.

SPRINGWORKS THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page).